Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06965192 · ClinicalTrials.gov registry record · NA

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

A NA study of Prostate Cancer and Kidney Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
2
Study locations

NCT06965192: Recruiting NA study of Prostate Cancer and Kidney Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06965192 is a NA study of Prostate Cancer and Kidney Cancer that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 220 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06965192, a NA study of Prostate Cancer and Kidney Cancer, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
2
Study locations

Study Summary

This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre- and 10 post-intervention patient encounters for each urologist with an accrual target of 200 unique patient visits (100 pre and 100 post-intervention) over a half-year period. Patient encounters pre- and post-intervention will be audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation. Patients and urologists will complete additional surveys on their perceptions of patient-provider communication. Urologists will further describe their experience and rate their satisfaction with visual decision support. Communication (content and perceived) will be compared pre- and post-intervention with secondary comparisons by race and care setting. It was hypothesized that the discussion of risks and benefits of cancer surgery will increase post-intervention and that the strength of recommendation and perceptions of patient-provider communication will change. The secondary hypothesis is that these changes will differ by patient race and care setting.

Primary Outcome

The impact of visual decision support on patient-physician communication will be assessed using coding-based thematic analysis of the debriefing interviews. The Informed Decision-Making coding system, which includes 9 elements which includes the nature of the clinical problem (e.g., cancer mortality risk, life expectancy), treatment options (e.g., surgery, alternatives), risks and benefits (e.g., complications, side effects, functional outcomes), and uncertainties (e.g., range of possible outcom

Interventions

  • OTHER No intervention
  • BEHAVIORAL Visual

Study Locations (2)

North Carolina

  • UNC Lineberger Comprehensive Cancer Center - Chapel Hill
  • New Hanover Regional Medical Center - Wilmington

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-04-24
Est. Completion 2028-01-30
Phase NA

What NCT06965192 shows while recruiting

NCT06965192 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (64% lower).

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.

NCT06965192 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06965192 about?

NCT06965192 is a clinical study titled "Designing Visual Tools to Enhance Cancer Surgeon Decision-making". This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre...

What is the current status of trial NCT06965192?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2025-04-24. Estimated completion is 2028-01-30.

What conditions does trial NCT06965192 study?

This clinical trial studies the following conditions: Prostate Cancer, Kidney Cancer.

What interventions are being tested in trial NCT06965192?

The interventions under investigation include: No intervention (OTHER), Visual (BEHAVIORAL).

Who is sponsoring clinical trial NCT06965192?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06965192 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06965192's enrollment target sits among peer trials

220 208th of 735 higher than 526 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06965192, the US trial registry maintained by the National Library of Medicine. NCT06965192 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.